Mupirocin Mounted Copper Nanoparticle Offered Augmented Drug Delivery against Resistant Bacteria
1, 2
- 1Student, Department of Pharmaceutics, Hindu College of Pharmacy, Sonipat, Haryana, INDIA.
- 2Associate Professor, Department of Pharmaceutics, Hindu College of Pharmacy, Sonipat, Haryana, INDIA.
CORRESPONDENCE
Dinesh Kaushik
Associate Professor Department of Pharmaceutics, Hindu College of Pharmacy, Sonipat, Haryana, INDIA.
Received: 15-09-2019; Accepted: 16-04-2020.
Volume 54, Issue 3 · pp. 637-646 · 2020 · DOI: 10.5530/ijper.54.3.113
ABSTRACT
Aim: In present investigation, mupirocin coupled copper nanoparticles were synthesized to overwhelm drug resistance in Staphylococcus aureus, responsible for dermal skin infections.Materials and Methods: Mupirocin (Anclaima Pvt. Ltd. India), copper sulphate (Thermo Fisher Scientific, India), Tri sodium citrate (Nice chemicals, India) Copper nanoparticles were produced by size reduction method by using Copper Sulphate and Tri sodium citrate. CuNPs were merged into gel base of carbopol which was formed by hot method. Carbapol gel shows no phase separation. Results and Discussion: The particle size of CuNPs was found to be 413.0± 30.2nm. The % EE was found to be 65.2%. On description unilamellar, sphere-shaped vesicles with soft surface were detected under transmission electron microscopy. XRD of CuNPs was found out crystalline in nature. The zeta potential of nanoparticle shows less aggregation of particle with - 15.1 ± 3.69 mV value. The amount of copper content was measured 5.9 microgram/10 mg of nanoparticles. In vitro release study of Cu NPs shows 96.5% release of drug and show effective antibacterial activity against Staphylococcus aureus.Conclusion: Mupirocin copper nanoparticles were produced and show excellent antibacterial activity upon S. aureus.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Verma, V., & Kaushik, D. (2020). Mupirocin Mounted Copper Nanoparticle Offered Augmented Drug Delivery against Resistant Bacteria. Indian Journal of Pharmaceutical Education and Research, 54(3), 637-646. https://doi.org/10.5530/ijper.54.3.113
Copyright and licence
© 2020 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited. CC BY 4.0